1. Bloom SL, Leveno KJ, Spong CY, Gilbert S, Hauth JC, Landon MB, et al. Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol. 2006. 108:6–11.
2. Mesleh R, Sultan M, Sabagh T, Algwiser A. Umbilical cord prolapse. J Obstet Gynecol. 1993. 13:24–28.
3. Yla-Outinen A, Heinonen PK, Tuimala R. Predisposing and risk factors of umbilical cord prolapse. Acta Obstet Gynecol Scand. 1985. 64:567–570.
4. Murphy DJ, MacKenzie IZ. The mortality and morbidity associated with umbilical cord prolapse. Br J Obstet Gynaecol. 1995. 102:826–830.
5. Levy H, Meier PR, Makowski EL. Umbilical cord prolapse. Obstet Gynecol. 1984. 64:499–502.
6. Bock JE, Wiese J. Prolapse of the umbilical cord. Acta Obstet Gynecol Scand. 1972. 51:303–308.
7. Alouini S, Mesnard L, Megier P, Lemaire B, Coly S, Desroches A. Management of umbilical cord prolapse and neonatal outcomes. J Gynecol Obstet Biol Reprod (Paris). 2010. 39:471–477.
8. Prabulos AM, Philipson EH. Umbilical cord prolapse. Is the time from diagnosis to delivery critical? J Reprod Med. 1998. 43:129–132.
9. Bythell V. Cord prolapse demands general anaesthesia. Int J Obstet Anesth. 2003. 12:287–289.
10. Scrutton M. Cord prolapse demands general anaesthesia. Int J Obstet Anesth. 2003. 12:290–292.
11. CESDI. Obstetric anaesthesia delays and complications. Confidential Enquiry Into Stillbirths and Deaths in Infancy, 7th annual report. 2000. London: Maternal and Child Health Research Consortium;41–52.
12. MacKenzie IZ, Cooke I. What is a reasonable time from decision-to-delivery by caesarean section? Evidence from 415 deliveries. BJOG. 2002. 109:498–504.
13. Wong JM. Propofol infusion syndrome. Am J Ther. 2010. 17:487–491.
14. Valtonen M, Kanto J, Rosenberg P. Comparison of propofol and thiopentone for induction of anaesthesia for elective caesarean section. Anaesthesia. 1989. 44:758–762.
15. Sanchez-Alcaraz A, Quintana MB, Laguarda M. Placental transfer and neonatal effects of propofol in caesarean section. J Clin Pharm Ther. 1998. 23:19–23.